Potential for cripto-1 in defining stem cell-like characteristics in human malignant melanoma

Cell Cycle

Volumn 7, Issue 13, 2008, Pages 1931-1935

  Strizzi, Luigi ^a   Abbott, Daniel E ^a   Salomon, David S ^b   Hendrix, Mary J C ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Cancer stem cells; Cerberus; Cripto 1; Lefty; Melanoma; Nanog; Nodal; Oct4; Tomoregulin

Indexed keywords

CD20 ANTIGEN; CELL PROTEIN; MULTIDRUG RESISTANCE PROTEIN 1; OCTAMER TRANSCRIPTION FACTOR 4; PROTEIN CRIPTO1; PROTEIN NODAL; TRANSCRIPTION FACTOR NANOG;

CANCER STEM CELL; CELL SUBPOPULATION; EPIGENETICS; HUMAN; MELANOMA; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; SKIN CARCINOGENESIS;

EID: 47749107233     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.7.13.6236     Document Type: Review

References (42)

1. Leiter U, Garbe C. Epidemiology of melanoma and nonmelanoma skin cancer - the role of sunlight. Adv Exp Med Biol 2008; 624:89-103.
2. Moan J, Porojnicu AC, Dahlback A. Ultraviolet radiation and malignant melanoma. Adv Exp Med Biol 2008; 624:104-16.
3. Clark WH Jr, Elder DE, Guerry DT, Epstein MN, Greene MH, Van Horn M. A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma. Hum Pathol 1984; 15:1147-65.
4. Balch CM, Soong SJ, Gershenwald JE, Thompson J F, Reintgen DS, Cascinelli N, Urist M, McMasters KM, Ross MI, Kirkwood JM, Atkins MB, Thompson JA, Coit DG, Byrd D, Desmond R, Zhang Y, Liu PY, Lyman GH, Morabito A. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol 2001; 19:3622-34.
5. Balch CM, Buzaid AC, Soong SJ, Atkins MB, Cascinelli N, Coit DG, Fleming ID, Gershenwald JE, Houghton A Jr, Kirkwood JM, McMasters KM, Mihm MF, Morton DL, Reintgen DS, Ross MI, Sober A, Thompson JA, Thompson J F. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol 2001; 19:3635-48.
6. Balch CM, Soong SJ, Smith T, Ross MI, Urist MM, Karakousis C P, Temple WJ, Mihm MC, Barnhill RL, Jewell WR, Wanebo HJ, Desmond R. Long-term results of a prospective surgical trial comparing 2 cm vs. 4 cm excision margins for 740 patients with 1-4 mm melanomas. Ann Surg Oncol 2001; 8:101-8.
7. Lui P, Cashin R, Machado M, Hemels M, Corey-Lisle PK, Einarson TR. Treatments for metastatic melanoma: synthesis of evidence from randomized trials. Cancer Treat Rev 2007; 33:665-80.
8. Postovit LM, Costa F F, Bischof JM, Seftor EA, Wen B, Seftor RE, Feinberg A P, Soares MB, Hendrix MJ. The commonality of plasticity underlying multipotent tumor cells and embryonic stem cells. J Cell Biochem 2007; 101:908-17.
9. Abbott DE, Postovit LM, Seftor EA, Margaryan N V, Seftor RE, Hendrix MJ. Exploiting the convergence of embryonic and tumorigenic signaling pathways to develop new therapeutic targets. Stem Cell Rev 2007; 3:68-78.
10. Hendrix MJ, Seftor EA, Hess AR, Seftor RE. Molecular plasticity of human melanoma cells. Oncogene 2003; 22:3070-5.
11. Hendrix MJ, Seftor EA, Hess AR, Seftor RE. Vasculogenic mimicry and tumour-cell plasticity: lessons from melanoma. Nature Rev Cancer 2003; 3:411-21.
12. Postovit LM, Margaryan NV, Seftor EA, Kirschmann DA, Lipavsky A, Wheaton WW, Abbott DE, Seftor RE, Hendrix MJ. Human embryonic stem cell microenvironment sup-presses the tumorigenic phenotype of aggressive cancer cells. Proc Natl Acad Sci USA 2008; 105:4329-34.
13. Schier A F, Shen MM. Nodal signalling in vertebrate development. Nature 2000; 403:385-9.
14. Vallier L, Reynolds D, Pedersen RA. Nodal inhibits differentiation of human embryonic stem cells along the neuroectodermal default pathway. Dev Biol 2004; 275:403-21.
15. Smith WC, McKendry R, Ribisi S Jr, Harland RM. A nodal-related gene defines a physical and functional domain within the Spemann organizer. Cell 1995; 82:37-46.
16. Tian T, Burrage K. Stochastic models for regulatory networks of the genetic toggle switch. Proc Natl Acad Sci USA 2006; 103:8372-7.
17. Schier A F. Nodal signaling in vertebrate development. Annu Rev Cell Dev Biol 2003; 19:589-621.
18. Collignon J, Varlet I, Robertson EJ. Relationship between asymmetric nodal expression and the direction of embryonic turning. Nature 1996; 381:155-8.
19. Tian T, Meng AM. Nodal signals pattern vertebrate embryos. Cell Mol Life Sci 2006; 63:672-85.
20. Gritsman K, Talbot WS, Schier A F. Nodal signaling patterns the organizer. Development 2000; 127:921-32.
21. Topczewska JM, Postovit LM, Margaryan NV, Sam A, Hess AR, Wheaton WW, Nickoloff BJ, Topczewski J, Hendrix MJ. Embryonic and tumorigenic pathways converge via Nodal signaling: role in melanoma aggressiveness. Nat Med 2006; 12:925-32.
22. Kulesa PM, Kasemeier-Kulesa JC, Teddy JM, Margaryan NV, Seftor EA, Seftor RE, Hendrix MJ. Reprogramming metastatic melanoma cells to assume a neural crest cell-like phenotype in an embryonic microenvironment. Proc Natl Acad Sci USA 2006; 103:3752-7.
23. Postovit LM, Seftor EA, Seftor RE, Hendrix MJ. A three-dimensional model to study the epigenetic effects induced by the microenvironment of human embryonic stem cells. Stem Cells 2006; 24:501-5.
24. Hendrix MJ, Seftor EA, Seftor RE, Kasemeier-Kulesa J, Kulesa PM, Postovit LM. Reprogramming metastatic tumour cells with embryonic microenvironments. Nature Rev Cancer 2007; 7:246-55.
25. Chen C, Shen MM. Tw o modes by which Lefty proteins inhibit nodal signaling. Curr Biol 2004; 14:618-24.
26. Harms PW, Chang C. Tomoregulin-1 (TMEFF1) inhibits nodal signaling through direct binding to the nodal coreceptor Cripto. Genes Dev 2003; 17:2624-9.
27. Hsu DR, Economides AN, Wang X, Eimon PM, Harland RM. The Xenopus dorsalizing factor Gremlin identifies a novel family of secreted proteins that antagonize BMP activities. Mol Cell 1998; 1:673-83.
28. Piccolo S, Agius E, Leyns L, Bhattacharyya S, Grunz H, Bouwmeester T, De Robertis EM. The head inducer Cerberus is a multifunctional antagonist of Nodal, BMP and Wnt signals. Nature 1999; 397:707-10.
29. Katoh M, Katoh M. WNT signaling pathway and stem cell signaling network. Clin Cancer Res 2007; 13:4042-5.
30. Armstrong L, Hughes O, Yung S, Hyslop L, Stewart R, Wappler I, Peters H, Walter T, Stojkovic P, Evans J, Stojkovic M, Lako M. The role of PI3K/AKT, MAPK/ERK and NFkappabeta signalling in the maintenance of human embryonic stem cell pluripotency and viability highlighted by transcriptional profiling and functional analysis. Hum Mol Genet 2006; 15:1894-913.
31. Scharenberg CW, Harkey MA, Torok-Storb B. The ABCG2 transporter is an efficient Hoechst 33342 efflux pump and is preferentially expressed by immature human hematopoietic progenitors. Blood 2002; 99:507-12.
32. Keshet GI, Goldstein I, Itzhaki O, Cesarkas K, Shenhav L, Yakirevitch A, Treves AJ, Schachter J, Amariglio N, Rechavi G. MDR1 expression identifies human melanoma stem cells. Biochem Biophys Res Commun 2008; 368:950-6.
33. Gottesman MM, Fojo T, Bates SE. Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer 2002; 2:48-58.
34. Monzani E, Facchetti F, Galmozzi E, Corsini E, Benetti A, Cavazzin C, Gritti A, Piccinini A, Porro D, Santinami M, Invernici G, Parati E, Alessandri G, La Porta CA. Melanoma contains CD1 33 and ABCG2 positive cells with enhanced tumourigenic potential. Eur J Cancer 2007; 43:935-46.
35. Fang D, Nguyen TK, Leishear K, Finko R, Kulp AN, Hotz S, Van Belle PA, Xu X, Elder DE, Herlyn M. A tumorigenic subpopulation with stem cell properties in melanomas. Cancer Res 2005; 65:9328-37.
36. Pan G, Thomson JA. Nanog and transcriptional networks in embryonic stem cell pluripotency. Cell Res 2007; 17:42-9.
37. Pan GJ, Chang ZY, Scholer HR, Pei D. Stem cell pluripotency and transcription factor Oct4. Cell Res 2002; 12:321-9.
38. Assou S, Le Carrour T, Tondeur S, Strom S, Gabelle A, Marty S, Nadal L, Pantesco V, Reme T, Hugnot J P, Gasca S, Hovatta O, Hamamah S, Klein B, De Vos J. A meta-analysis of human embryonic stem cells transcriptome integrated into a web-based expression atlas. Stem Cells 2007; 25:961-73.
39. Loh YH, Wu Q, Chew JL, Vega VB, Zhang W, Chen X, Bourque G, George J, Leong B, Liu J, Wong KY, Sung KW, Lee CW, Zhao XD, Chiu KP, Lipovich L, Kuznetsov VA, Robson P, Stanton LW, Wei CL, Ruan Y, Lim B, Ng HH. The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells. Nat Genet 2006; 38:431-40.
40. Strizzi L, Bianco C, Normanno N, Salomon D. Cripto-1: a multifunctional modulator during embryogenesis and oncogenesis. Oncogene 2005; 24:5731-41.
41. Mallikarjuna K, Vaijayanthi P, Krishnakumar S. Cripto-1 expression in uveal melanoma: an immunohistochemical study. Exp Eye Res 2007; 84:1060-6.
42. Liguori GL, Borges AC, D'Andrea D, Liguoro A, Goncalves L, Salgueiro AM, Persico MG, Belo JA. Cripto-independent Nodal signaling promotes positioning of the A-P axis in the early mouse embryo. Dev Biol 2008; 315:280-9.